J&J Stent Patent Suit Damages From Medtronic Include $77 Mil. In Royalties

Johnson & Johnson's $271.1 mil. damages award in its stent patent suit against rival Medtronic includes roughly $77 mil. in royalties.

More from Archive

More from Medtech Insight